Akèy › Myelom Miltip › New York › Buffalo
Etid klinik pou Myelom Miltip nan Buffalo, NY
10 etid pou Myelom Miltip ap chèche patisipan nan sit nan ak bò kote Buffalo (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Ap rekriteFaz 4
- Roswell Park Cancer Institute, Buffalo
Collection of Tissue Samples for Cancer Research
Ap rekriteEtid obsèvasyon
- Roswell Park Cancer Institute, Buffalo
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Ap rekriteFaz 2
- Roswell Park Cancer Institute, Buffalo
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
Ap rekriteFaz 1/2
- Roswell Park Comprehensive Cancer Center, Buffalo
Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary Disease
Ap rekriteFaz 2
- Roswell Park Cancer Institute, Buffalo
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
Ap rekriteFaz 1/2
- Research Site, Buffalo
SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Ap rekriteFaz 1
- Roswell Park Comprehensive Cancer Center, Buffalo
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Ap rekriteFaz 1
- Roswell Park Cancer Institute, Buffalo
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Ap rekriteFaz 1/2
- Roswell Park Comprehensive Cancer Center, Buffalo
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
Ap rekrite
- Roswell Park Cancer Institute, Buffalo
Etid Myelom Miltip nan lòt vil
- New York City, NY60 etid
- Boston, MA42 etid
- Atlanta, GA41 etid
- Houston, TX38 etid
- Durham, NC37 etid
- Nashville, TN32 etid
- Denver, CO27 etid
- Rochester, MN24 etid
- St. Louis, MO24 etid
- Columbus, OH24 etid
- Baldwin Park, CA23 etid
- Chicago, IL22 etid
Lòt etid nan Buffalo
- Kansè (tout kalite)19 etid
- Leksemi mieloïd egi19 etid
- Kansè Poumon ki pa ti selil18 etid
- Kansè poumon16 etid
- Kansè nan tete16 etid
- Kansè ovè13 etid
- Kansè pwostat11 etid
- Kansè Metastatik11 etid
- Melanom10 etid
- Obèsite9 etid
- Limfòm Burkitt8 etid
- Sendwòm myelodisplastik8 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.